“Vascular inflammation and cardiovascular disease: review about the role of PET imaging”

Libby P (2002) Inflammation in atherosclerosis. Nature 420:868–874. https://doi.org/10.1038/nature01323

Ley K, Miller YI, Hedrick CC (2011) Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol 31:1506. https://doi.org/10.1161/ATVBAHA.110.221127

Galkina E, Ley K (2007) Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27:2292. https://doi.org/10.1161/ATVBAHA.107.149179

Woollard KJ et al (2010) Monocytes in atherosclerosis: Subsets and functions. Nat Rev Cardiol 7(2):77–86. https://doi.org/10.1038/nrcardio.2009.228

Hutcheson JD, Goettsch C, Bertazzo S et al (2016) Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques. Nat Mater 15:335–343. https://doi.org/10.1038/nmat4519

Ridker PM, Everett BM, Thuren T et al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. NEJM 377:1119–1131. https://doi.org/10.1056/NEJMoa1707914

Libby P (2013) Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 368:2004–2013. https://doi.org/10.1056/NEJMra1216063

Gomes A, Glaudemans A, Touw DJ et al (2017) Diagnostic value of imaging in infective endocarditis: a systematic review. Lancet Infect Dis 17(1):e1–e14. https://doi.org/10.1016/S1473-3099(16)30141-4

Casali M, Lauri C, Altini C et al (2021) State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Transl Imaging 9(4):299–339. https://doi.org/10.1007/s40336-021-00445-w

Juneau D, Golfam M, Hazra S et al (2017) Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device infection: a systematic review and meta-analysis. Circ Cardiovasc Imaging 10(4):e005772. https://doi.org/10.1161/CIRCIMAGING.116.005772

Ploux S, Riviere A, Amraoui S et al (2011) Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm 8(9):1478–1481. https://doi.org/10.1016/j.hrthm.2011.03.062

Treglia G, Annunziata S, Sobic-Saranovic D et al (2014) The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review. Acad Radiol 21:675–684

Ahmadian A, Brogan A, Berman J et al (2014) Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol 21:925–939

Blankstein R, Osborne M, Naya M et al (2014) Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 63:329–336

Pelletier-Galarneau M, Ruddy TD (2019) PET/CT for diagnosis and management of large-vessel vasculitis. Curr Cardiol Rep 21(5):34. https://doi.org/10.1007/s11886-019-1122-z

Soussan M, Nicolas P, Schramm C et al (2015) Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine (Baltimore) 94(14):e622. https://doi.org/10.1097/MD.0000000000000622

Le Guludec D, Lautamäki R, Knuuti J et al (2008) Present and future of clinical cardiovascular PET imaging in Europe—a position statement by the European Council of Nuclear Cardiology (ECNC). Eur J Nucl Med Mol Imaging 35(9):1709–1724. https://doi.org/10.1007/s00259-008-0859-1

Skagen K, Johnsrud K, Evensen K et al (2015) Carotid plaque inflammation assessed with (18)F-18F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients. Int J Stroke 10(5):730–736. https://doi.org/10.1111/ijs.12430

Rudd JHF, Narula J, William Strauss H et al (2010) Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol 55(23):2527–2535. https://doi.org/10.1016/j.jacc.2009.12.061

Gaemperli O, Boyle JJ, Rimoldi OE et al (2010) Molecular imaging of vascular inflammation. Eur J Nucl Med Mol Imaging 37:1236. https://doi.org/10.1007/s00259-009-1371-y

Syed MB, Fletcher AJ, Forsythe RO et al (2019) Emerging techniques in atherosclerosis imaging. Br J Radiol 92(1103):20180309. https://doi.org/10.1259/bjr.20180309

Takx RA, Partovi S, Ghoshhajra BB (2016) Imaging of atherosclerosis. Int J Cardiovasc Imaging 32:5–12. https://doi.org/10.1007/s10554-015-0730-y

Sanz J, Fayad ZA (2008) Imaging of atherosclerotic cardiovascular disease. Nature 451(7181):953–957. https://doi.org/10.1038/nature06803

Grammaticos PC (2014) Diagnosing atherosclerosis makes nuclear medicine a tissue imaging modality. Hell J Nucl Med 17(1):12

Buscombe JR (2015) Exploring the nature of atheroma and cardiovascular inflammation in vivo using positron emission tomography (PET). Br J Radiol 88(1053):20140648. https://doi.org/10.1259/bjr.20140648

Ogawa M, Ishino S, Mukai T et al (2004) (18)F-18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 45(7):1245–1250

Leppänen O, Björnheden T, Evaldsson M et al (2006) ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo. Atherosclerosis 188(2):323–330. https://doi.org/10.1016/j.atherosclerosis.2005.11.017

Tawakol A, Migrino RQ, Hoffmann U et al (2005) Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 12(3):294–301. https://doi.org/10.1016/j.nuclcard.2005.03.002

Tawakol A et al (2006) In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48(9):1818–1824. https://doi.org/10.1016/j.jacc.2006.05.076

Duivenvoorden R, Mani V, Woodward M et al (2013) Relationship of serum inflammatory biomarkers with plaque inflammation assessed by 18F-FDG PET/CT: the dal-PLAQUE study. JACC Cardiovasc Imaging 6(10):1087–1094. https://doi.org/10.1016/j.jcmg.2013.03.009

Tahara N, Kai H, Yamagishi S et al (2007) Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 49(14):1533–1539. https://doi.org/10.1016/j.jacc.2006.11.046

Al-Zaghal A, Raynor W, Khosravi M et al (2018) Applications of PET imaging in the evaluation of musculoskeletal diseases among the geriatric population. Semin Nucl Med 48(6):525–534. https://doi.org/10.1053/j.semnuclmed.2018.07.002

Paydary K, Revheim M-E, Emamzadehfard S et al (2020) Quantitative thoracic aorta calcification assessment by (18)F-18F-NaF PET/CT and its correlation with atherosclerotic cardiovascular disorders and increasing age. Eur Radiol 31(2):785–794. https://doi.org/10.1007/s00330-020-07133-9

Raynor WY, Borja J, Rojulpote C et al (2021) 18-sodium fluoride: an emerging tracer to assess active vascular microcalcification. J Nucl Cardiol 28(6):2706–2711. https://doi.org/10.1007/s12350-020-02138-9

Fujimoto K, NorikanE T, YamamotO Y et al (2019) Association between carotid (18)F-18F-NaF and (18)F-18F-FDG uptake on PET/CT with ischemic vascular brain disease on MRI in patients with carotid artery disease. Ann Nucl Med 33(12):907–915. https://doi.org/10.1007/s12149-019-01403-3

McKenney-Drake ML, Moghbel MC, PaydarY K et al (2018) (18)F-18F-NaF and (18)F-18F-FDG as molecular probes in the evaluation of atherosclerosis. Eur J Nucl Med Mol Imaging 45(12):2190–2200. https://doi.org/10.1007/s00259-018-4078-0

Alavi A, Werner TJ, Raynor W et al (2021) Critical review of PET imaging for detection and characterization of the atherosclerotic plaques with emphasis on limitations of 18F-FDG-PET compared to 18F-NaF-PET in this setting. Am J Nucl Med Mol Imaging 15(11):337–351

Piri R, Gauher Lici G, Riyahimanesh P et al (2021) Two-year change in 18F-sodium fluoride uptake in major arteries of healthy subjects and angina pectoris patients. Int J Cardiovasc Imaging 37(10):3115–3126. https://doi.org/10.1007/s10554-021-02263-7

Høilund-Carlsen PF, Piri R, Constantinescu C et al (2020) Atherosclerosis Imaging with 18F-Sodium Fluoride PET. Diagnostics 10(10):852. https://doi.org/10.3390/diagnostics10100852

Arani LS, Gharavi MH, Zadeh MZ et al (2019) Association between age, uptake of 18F-fluorodeoxyglucose and of 18F-sodium fluoride, as cardiovascular risk factors in the abdominal aorta. Hell J Nucl Med 22(1):14–19. https://doi.org/10.1967/s002449910954

Sorci O, Batzdorf AS, Mayeret M et al (2020) 18F-sodium fluoride PET/CT provides prognostic clarity compared to calcium and Framingham risk scoring when addressing whole-heart arterial calcification. Eur J Nucl Med Mol Imaging 47(7):1678–1687. https://doi.org/10.1007/s00259-019-04590-3

Aziz K, Berger K, Claycombe K et al (2008) Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography. Circulation 117(16):2061–2070. https://doi.org/10.1161/CIRCULATIONAHA.106.652313

Arauz A, Hoyos L, Zenteno M et al (2007) Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography. Pilot study. Clin Neurol Neurosurg 109(5):409–412. https://doi.org/10.1016/j.clineuro.2007.02.012

McCabe JJ, Pol C-R, Giannotti N et al (2021) Carotid plaque inflammation imaged by PET and prediction of recurrent stroke at 5 years. Neurology 97(23):e2282–e2291. https://doi.org/10.1212/WNL.0000000000012909

Rominger A, Saam T, Wolpers S et al (2009) 18F–18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med 50(10):1611–1620. https://doi.org/10.2967/jnumed.109.065151

van der Valk FM, Verweij SL, Zwinderman KAH et al (2016) Thresholds for arterial wall inflammation quantified by 18F-FDG PET imaging: implications for vascular interventional studies. JACC: Cardiovasc Imaging 9(10):1198–1207. https://doi.org/10.1016/j.jcmg.2016.04.007

Bural GG, Torigian DA, Sözmen M et al (2018) Comparison of atherosclerotic inflammation and calcification in subjects with end stage renal disease (ESRD) on hemodialysis to normal controls utilizing (18)F-18F-FDG PET/CT. Hell J Nucl Med 21(3):169–174. https://doi.org/10.1967/s002449910901

Vanfleteren LE, van Meerendonk AMG, Franssen FM et al (2014) A possible link between increased metabolic activity of fat tissue and aortic wall inflammation in subjects with COPD. A retrospective 18F–18F-FDG-PET/CT pilot study. Respir Med 108:883–890. https://doi.org/10.1016/j.rmed.2014.04.001

Joshi AA, Lerman JB, Dey AK et al (2018) Association between aortic vascular inflammation and coronary artery plaque characteristics in psoriasis. JAMA Cardiol 3(10):949–956. https://doi.org/10.1001/jamacardio.2018.2769

Watanabe T, Kawasaki M, Tanaka R et al (2015) Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study). Cardiovasc Ultrasound 2(13):17. https://doi.org/10.1186/s12947-015-0012-9

Mizoguchi M, Tahara N, Tahara A et al (2011) Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial 18F-FDG PET/CT imaging study of carotid artery and ascending aorta. JACC Cardiovasc Imaging 4(10):1110–1118. https://doi.org/10.1016/j.jcmg.2011.08.007

Ridker PM, Thuren T, Zalewski A et al (2011) Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am Heart J 162:597–605

Tardif JC, Kouz S, Waters DD et al (2019) Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 381(26):2497–2505. https://doi.org/10.1056/NEJMoa1912388

Tahara N, Kai H, Ishibashi M et al (2006) Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48(9):1825–1831. https://doi.org/10.1016/j.jacc.2006.03.069

Tawakol A, Fayad ZA, Mogg R et al (2013) Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: Results of a Multicenter Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Feasibility Study. J Am Coll Cardiol 62(10):909–917. https://doi.org/10.1016/j.jacc.2013.04.066

Cannon CP, Braunwald E, McCabe CH et al (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350:1495–1504

Ray KK, Cannon CP, McCabe CH et al (2005) for the PROVE IT-TIMI 22 investigators early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 46:1405–1410

Thuy Trang DAMT, Okamura K, Suto T et al (2021) Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients? Arthritis Res Ther 23(1):206. https://doi.org/10.1186/s13075-021-02585-w

Kaijasilta J-P, Kerola AM, Tuompo R et al (2022) Adalimumab and sulfasalazine in alleviating sacroiliac and aortic inflammation detected in PET/CT in patients with axial spondyloarthritis: PETSPA. Immun Inflamm Dis 10(2):155–162. https://doi.org/10.1002/iid3.552

Jensen JK, Binderup T, Grandjean CE et al (2022) Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis. Atherosclerosis 352:88–95. https://doi.org/10.1016/j.atherosclerosis.2022.03.032

Camici PG, Rimoldi QE, Gaemperli O, Libby P et al (2012) Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque. Eur Heart J 33(11):1309–1317. https://doi.org/10.1093/eurheartj/ehs067

Alavi A, Werner TJ, Raynor W et al (2021) Critical review of PET imaging for detection and characterization of the atherosclerotic plaques with emphasis on limitations of 18F-FDG-PET compared to 18F-NaF-PET in this setting. Am J Nucl Med Mol Imaging 11(5):337–351

Folco EJ, Sheikine Y, Rocha VZ et al (2011) Hypoxia but not inflammation augments glucose uptake in human macrophages. Implications for imaging atherosclerosis with 18F-FDG-PET. J Am Coll Cardiol 58(6):603–614. https://doi.org/10.1016/j.jacc.2011.03.044

Wykrzykowska J, Lehman S, Williams G et al (2009) Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 50(4):563–568. https://doi.org/10.2967/jnumed.108.055616

Dunphy MP, Freiman A, Larson SM et al (2005) Association of vascular 18F-18F-FDG uptake with vascular calcification. J Nucl Med 46(8):1278–1284

Rogers IS, Nasir K, Figueroa AL et al (2010) Feasibility of 18F-FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging 3(4):388–397. https://doi.org/10.1016/j.jcmg.2010.01.004

Joshi NV, Vesey AT, Williams MC et al (2014) 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet 383(9918):705–713. https://doi.org/10.1016/S0140-6736(13)61754-7

Dweck MR, Chow MWL, Joshi NV et al (2012) Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol 59(17):1539–1548. https://doi.org/10.1016/j.jacc.2011.12.037

Nakahara T, Dweck MR, Narula N et al (2017) Coronary artery calcification: from mechanism to molecular imaging. JACC Cardiovasc Imaging 10(5):582–593

Blomberg BA, Thomassen A, Takx RAP et al (2014) Delayed 18F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA study. J Nucl Cardiol 21(3):588–597. https://doi.org/10.1007/s12350-014-9884-6

Blomberg BA, de Jong PA, Thomassen A et al (2017) Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: results of the CAMONA study. Eur J Nucl Med Mol Imaging 44(2):249–258. https://doi.org/10.1007/s00259-016-3552-9

Senders M, Hernot S, Carlucci G et al (2019) Nanobody-facilitated multiparametric PET/MRI phenotyping of atherosclerosis. JACC Cardiovasc Imaging 12:2015–2026. https://doi.org/10.1016/j.jcmg.2018.07.027

Gaemperli O, Shalhoub J, Owen D et al (2012) Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J 33:1902–1910. https://doi.org/10.1093/eurheartj/ehr367

Luehmann H, Detering L, Gropler RJ et al (2017) C–C chemokine receptor type 2 (CCR2) targeted PET imaging of early atherosclerosis. Circ Am Heart Assoc 136:A20674

Woodard PK, Liu Y, Pressly ED et al (2016) Design and modular construction of a polymeric nanoparticle for targeted atherosclerosis positron emission tomography imaging: a story of 25% (64)Cu-CANF-Comb. Pharm Res 33:2400–2410. https://doi.org/10.1007/s11095-016-1963-8

Prigentl K, Vigne J (2021) Advances in radiopharmaceutical sciences for vascular inflammation imaging: focus on clinical applications. Molecules 26(23):7111. https://doi.org/10.3390/molecules26237111